Results 231 to 240 of about 2,244,987 (335)

YAP1::TFE3 mediates endothelial‐to‐mesenchymal plasticity in epithelioid hemangioendothelioma

Molecular Oncology, EarlyView.
The YAP1::TFE3 fusion protein drives endothelial‐to‐mesenchymal transition (EndMT) plasticity, resulting in the loss of endothelial characteristics and gain of mesenchymal‐like properties, including resistance to anoikis, increased migratory capacity, and loss of contact growth inhibition in endothelial cells.
Ant Murphy, Samuel Hartzler, Paula A. Vargas Carranza, Shyaman Jayasundara, Madison E. Yates, Nimod D. Janson, Bozhi Liu, Annaleigh Benton, Majid Kazemian, Jason A. Hanna   +9 more
wiley   +1 more source

Integrative modeling of FOXO-mediated autophagy in NSCLC: linking cGAS-STING signaling to IL-6 dynamics. [PDF]

Front Oncol
Rani D, Khandibharad S, Singh S.
europepmc   +1 more source

Elevated serum levels of IL-6 and CXCL9 in autoimmune retinopathy (AIR) patients [PDF]

, 2017
Barbara Detrick, Sapna Gangaputra, Doreen N. Palsgrove, Christopher D. Heaney, John J. Hooks, H. Nida Sen   +5 more
openalex   +1 more source

Emerging role of ARHGAP29 in melanoma cell phenotype switching

Molecular Oncology, EarlyView.
This study gives first insights into the role of ARHGAP29 in malignant melanoma. ARHGAP29 was revealed to be connected to tumor cell plasticity, promoting a mesenchymal‐like, invasive phenotype and driving tumor progression. Further, it modulates cell spreading by influencing RhoA/ROCK signaling and affects SMAD2 activity. Rho GTPase‐activating protein
Beatrice Charlotte Tröster, Melanie Kappelmann‐Fenzl, Anja Katrin Bosserhoff, Nicole Rachinger   +3 more
wiley   +1 more source

Polymorphisms in rs2069845 are associated with IL-6 and soluble IL-6 receptor levels during total joint replacement. [PDF]

PLoS One
Anderson KD, Dulion B, Wong J, Patel N, DeBenedetti A, Della Valle CJ, Ross RD.   +6 more
europepmc   +1 more source

Role of pre-operative serum IL-6 and CA-125 in the prediction of malignant ovarian tumor

Rowson Ara, Shirin Akter Begum, Farhana Khatoon, Mehriban Amatullah, Subrina Meher, Anjuman Sultana, Moushume Akther, Fatema Nihar, Sunzia Sayed   +8 more
openalex   +2 more sources

Novel neurotrophin-1/B cell-stimulating factor-3: A cytokine of the IL-6 family

, 1999
Giorgio Senaldi, Brian Varnum, Ulla M. Sarmiento, Charlie Starnes, Jackson Lile, Sheila Scully, Jane Guo, Gary Elliott, Jennifer McNinch, Christine L. Shaklee, Dan Freeman, Frank Manu, W. Scott Simonet, Thomas C. Boone, Ming‐Shi Chang   +14 more
openalex   +2 more sources

Gut microbiota diversity is prognostic in metastatic hormone receptor‐positive breast cancer patients receiving chemotherapy and immunotherapy

Molecular Oncology, EarlyView.
In this exploratory study, we investigated the relationship between the gut microbiota and outcome in patients with metastatic hormone receptor‐positive breast cancer, treated in a randomized clinical trial with chemotherapy alone or chemotherapy in combination with immune checkpoint blockade.
Andreas Ullern, Kristian Holm, Nikolai Kragøe Andresen, Andreas Hagen Røssevold, Corinna Bang, Bjørn Naume, Johannes R. Hov, Jon Amund Kyte   +7 more
wiley   +1 more source

Neonatal infections in Lubumbashi, in the Democratic Republic of Congo: Correlation between C-reactive protein (CRP), interleukin-6 (IL-6) and procalcitonin (PCT)

Fazili, Arold, Buteka, Cynthia, KAPINGA, Victoire, Mujinga, Gradine, ABASI, Armand, KALOBA, Gloire, MULIMBI, Grégoire   +6 more
openalex   +1 more source

ORIGINAL PAPER The value of the assessment of interleukin-6 (IL-6), matrix metalloproteinases and their inhibitors in serum in the assessment of rheumatoid arthritis activity [PDF]

, 2005
Piotr Adrian Klimiuk, Stanisław Sierakowski, Ewa Gińdzieńska‐Sieśkiewicz, Justyna Chwiećko   +3 more
openalex